EMBED 3.0 study manufacturing for Cardiff University goes to ProMed Pharma
- Cardiff University
- Wales
- Direct
- 11 May 2026 to 31 December 2026
Cardiff University hired ProMed Pharma, LLC to develop and manufacture the product for the EMBED 3.0 research study. Making it involves microinjection-moulding formulations that contain active pharmaceutical ingredients.
Those technical demands were so specific that the university chose to keep production apart from the study's clinical trial services, with a separate supplier for each. The EMBED team and the study's funder put finding a contract development and manufacturing organisation first.
The university awarded the contract directly in April 2026. It runs to December 2026, and no value was published.
Contract ends December 2026
- What
- Aseptic compounding, specials and contract pharmaceutical manufacturing
- Buyer
- Cardiff University
- Supplier
- ProMed Pharma, LLC
- Value
- Not published
- How it was bought
- Direct
- Dates and next
- May 2026 to Dec 2026